Please complete this form to help us route your request to the appropriate Sales team.
We can only answer sales queries via this form. If you need product support or training, please visit our Customer Support Center.


By submitting this request you are opting in to receive our emails. Each email we send you will include the option to opt out of receiving future mailings. View our privacy policy.


       Intellectual Property & Science is now known as Clarivate Analytics, and is no longer part of Thomson Reuters >>

The good times are rolling for the life sciences as dealmaking continues unimpeded. But how do you stay on top of trends and deals? And how do you identify early stage opportunities?

The Dealmaker’s Playbook draws on BioWorld, Cortellis Competitive Intelligence, and Recap to give you the full picture on the potential deals across the life sciences.

Recap: Search for potential partners, conduct due diligence, assess deal value, explore deal structures and terms, and determine statistical technical success rates. From broad market wide trends to tightly focused comparables, Recap helps you make better decisions faster.
Cortellis Competitive Intelligence: Tracks all drugs in commercial development for all indications, companies, industry deals, patents, clinical trials, and more.  With Cortellis, you can easily see what types of drugs are in development, where, by whom, and for what indication. 
(Download Factsheet)(Watch Video, 2 minutes 55 seconds)